GP-1.2

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameGP-1.2

Drug Alias NameT-cell immune response cDNA 7 (GenPat77)TIRC7 inhibitors (GenPat77)TIRC7 inhibitors (MedImmune)T-cell immune response cDNA 7 inhibitors (MedImmune)

ClassificationBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionImmunomodulatorsNeuroprotectantsT lymphocytes inhibitors

TargetsUpdating

Therapy Area/IndicationsRejection of organ transplantationInflammationAutoimmune Diseases +[8]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesGermany

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGenPat77 Pharmacogenetics AG

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGenPat77 Pharmacogenetics AG Medimmune Llc

Active IndicationsN/A

Inactive IndicationsRejection of organ transplantationInflammationAutoimmune Diseases +[8]

Other Information

ATC CodeN/A